Goldenberg M, Lanzkron S, Pecker L
Expert Rev Hematol. 2024; 17(12):891-905.
PMID: 39499235
PMC: 11669372.
DOI: 10.1080/17474086.2024.2423368.
Krishnamurti L
Hematology Am Soc Hematol Educ Program. 2021; 2021(1):181-189.
PMID: 34889368
PMC: 8791142.
DOI: 10.1182/hematology.2021000251.
Lattanzi A, Camarena J, Lahiri P, Segal H, Srifa W, Vakulskas C
Sci Transl Med. 2021; 13(598).
PMID: 34135108
PMC: 8862191.
DOI: 10.1126/scitranslmed.abf2444.
Orkin S
Med. 2021; 2(2):122-136.
PMID: 33688634
PMC: 7939134.
DOI: 10.1016/j.medj.2020.12.011.
Krishnamurti L
Front Pediatr. 2021; 8:551170.
PMID: 33469520
PMC: 7813811.
DOI: 10.3389/fped.2020.551170.
Therapeutic gene editing strategies using CRISPR-Cas9 for the β-hemoglobinopathies.
Papizan J, Porter S, Sharma A, Pruett-Miller S
J Biomed Res. 2020; 35(2):115-134.
PMID: 33349624
PMC: 8038529.
DOI: 10.7555/JBR.34.20200096.
Preclinical Evaluation of a Novel Lentiviral Vector Driving Lineage-Specific BCL11A Knockdown for Sickle Cell Gene Therapy.
Brendel C, Negre O, Rothe M, Guda S, Parsons G, Harris C
Mol Ther Methods Clin Dev. 2020; 17:589-600.
PMID: 32300607
PMC: 7150438.
DOI: 10.1016/j.omtm.2020.03.015.
End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings.
Farrell A, Panepinto J, Desai A, Kassim A, Lebensburger J, Walters M
Blood Adv. 2019; 3(23):4002-4020.
PMID: 31809537
PMC: 6963248.
DOI: 10.1182/bloodadvances.2019000883.
Genome editing of HBG1 and HBG2 to induce fetal hemoglobin.
Metais J, Doerfler P, Mayuranathan T, Bauer D, Fowler S, Hsieh M
Blood Adv. 2019; 3(21):3379-3392.
PMID: 31698466
PMC: 6855127.
DOI: 10.1182/bloodadvances.2019000820.
How I treat sickle cell disease with hematopoietic cell transplantation.
Stenger E, Shenoy S, Krishnamurti L
Blood. 2019; 134(25):2249-2260.
PMID: 31697818
PMC: 6923666.
DOI: 10.1182/blood.2019000821.
Extensive multilineage analysis in patients with mixed chimerism after allogeneic transplantation for sickle cell disease: insight into hematopoiesis and engraftment thresholds for gene therapy.
Magnani A, Pondarre C, Bouazza N, Magalon J, Miccio A, Six E
Haematologica. 2019; 105(5):1240-1247.
PMID: 31537695
PMC: 7193509.
DOI: 10.3324/haematol.2019.227561.
Curative Therapies for Sickle Cell Disease.
Khemani K, Katoch D, Krishnamurti L
Ochsner J. 2019; 19(2):131-137.
PMID: 31258425
PMC: 6584191.
DOI: 10.31486/toj.18.0044.
Bone marrow transplantation for adolescents and young adults with sickle cell disease: Results of a prospective multicenter pilot study.
Krishnamurti L, Neuberg D, Sullivan K, Kamani N, Abraham A, Campigotto F
Am J Hematol. 2019; 94(4):446-454.
PMID: 30637784
PMC: 6542639.
DOI: 10.1002/ajh.25401.
Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease.
Poletti V, Urbinati F, Charrier S, Corre G, Hollis R, Campo Fernandez B
Mol Ther Methods Clin Dev. 2018; 11:167-179.
PMID: 30533448
PMC: 6276308.
DOI: 10.1016/j.omtm.2018.10.014.
Gene Therapy for Hemoglobinopathies.
Cavazzana M, Mavilio F
Hum Gene Ther. 2018; 29(10):1106-1113.
PMID: 30200783
PMC: 6196755.
DOI: 10.1089/hum.2018.122.
Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells.
DeWitt M, Magis W, Bray N, Wang T, Berman J, Urbinati F
Sci Transl Med. 2016; 8(360):360ra134.
PMID: 27733558
PMC: 5500303.
DOI: 10.1126/scitranslmed.aaf9336.
CRISPR/Cas9-Mediated Correction of the Sickle Mutation in Human CD34+ cells.
Hoban M, Lumaquin D, Kuo C, Romero Z, Long J, Ho M
Mol Ther. 2016; 24(9):1561-9.
PMID: 27406980
PMC: 5113113.
DOI: 10.1038/mt.2016.148.
Use of genome-editing tools to treat sickle cell disease.
Tasan I, Jain S, Zhao H
Hum Genet. 2016; 135(9):1011-28.
PMID: 27250347
PMC: 5002234.
DOI: 10.1007/s00439-016-1688-0.
Gene Therapy for Hemoglobinopathies: Tremendous Successes and Remaining Caveats.
Malik P
Mol Ther. 2016; 24(4):668-70.
PMID: 27081721
PMC: 4886952.
DOI: 10.1038/mt.2016.57.
Genetic treatment of a molecular disorder: gene therapy approaches to sickle cell disease.
Hoban M, Orkin S, Bauer D
Blood. 2016; 127(7):839-48.
PMID: 26758916
PMC: 4760089.
DOI: 10.1182/blood-2015-09-618587.
